The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of Spanish hospitals involved in the Quality Oncology Practice Initiative program.
 
Jesus Garcia-Foncillas
Honoraria - Bayer; Merck KGaA (Inst); Novartis; Sanofi; SERVIER (Inst)
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Janssen
 
Rafael Lopez
Stock and Other Ownership Interests - Diversa Technologies; Nasasbiotech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; lilly; MSD; Roche; Rovi
Speakers' Bureau - BMS; Lilly; Novartis; Pfizer; PharmaMar; Roche; Rovi
Research Funding - Lilly (Inst); Merck (Inst); Roche (Inst)
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pierre Fabre; Roche; Tesaro
 
Carlos Camps
No Relationships to Disclose
 
Vicente Guillem
No Relationships to Disclose
 
Jose Luis Alonso
No Relationships to Disclose
 
Alfredo Carrato
Consulting or Advisory Role - Baxter; Hutchison MediPharma; Mylan
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - BMS; MSD Oncology
 
Nicole Martín
No Relationships to Disclose
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Hutchmed (I); Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Mariano Provencio
No Relationships to Disclose
 
Emilio Esteban
No Relationships to Disclose
 
Francisco Ayala
No Relationships to Disclose
 
Pedro Pérez-Segura
No Relationships to Disclose
 
Javier Narbona
No Relationships to Disclose
 
Juan L. Bayo
No Relationships to Disclose
 
Maria Bessa
No Relationships to Disclose
 
Paula Gratal
No Relationships to Disclose